Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
1,364,360
-
Share change
-
+57,268
-
Total reported value
-
$748,757
-
Price per share
-
$0.55
-
Number of holders
-
50
-
Value change
-
-$5,861
-
Number of buys
-
22
-
Number of sells
-
9
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q1 2025
As of 31 Mar 2025,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,364,360 shares.
The largest 10 holders included
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, FRANKLIN RESOURCES INC, COMMONWEALTH EQUITY SERVICES, LLC, CIBC WORLD MARKET INC., Badgley Phelps Wealth Managers, LLC, and BANK OF MONTREAL /CAN/.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.